SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-041807
Filing Date
2022-04-01
Accepted
2022-04-01 16:54:50
Documents
19
Period of Report
2022-03-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2211208d1_8k.htm   iXBRL 8-K 36915
2 EXHIBIT 1.1 tm2211208d1_ex1-1.htm EX-1.1 311487
3 EXHIBIT 4.1 tm2211208d1_ex4-1.htm EX-4.1 93817
4 EXHIBIT 5.1 tm2211208d1_ex5-1.htm EX-5.1 12450
5 EXHIBIT 99.1 tm2211208d1_ex99-1.htm EX-99.1 6227
6 EXHIBIT 99.2 tm2211208d1_ex99-2.htm EX-99.2 10429
10 GRAPHIC image_001.jpg GRAPHIC 2277
11 GRAPHIC image_002.jpg GRAPHIC 1659
  Complete submission text file 0001104659-22-041807.txt   765699

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA sls-20220331.xsd EX-101.SCH 3060
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE sls-20220331_lab.xml EX-101.LAB 34476
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sls-20220331_pre.xml EX-101.PRE 22614
13 EXTRACTED XBRL INSTANCE DOCUMENT tm2211208d1_8k_htm.xml XML 3610
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 22799107
SIC: 2834 Pharmaceutical Preparations